Evidence map›Paper›PMID 33291474›Full record

ArticleMolecules (Basel, Switzerland)2020

Permeation of β-Lactamase Inhibitors through the General Porins of Gram-Negative Bacteria.

Alessandro Pira, Mariano Andrea Scorciapino, Igor V Bodrenko, Andrea Bosin, Silvia Acosta-Gutiérrez, Matteo Ceccarelli

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Alessandro PiraDepartment of Physics, University of Cagliari, Cittadella Universitaria di Monserrato, 09042 Monserrato, Italy.ORCID 0000-0003-3380-4403
Mariano Andrea ScorciapinoDepartment of Chemical and Geological Sciences, University of Cagliari, Cittadella Universitaria di Monserrato, 09042 Monserrato, Italy.ORCID 0000-0001-7502-7265
Igor V BodrenkoCNR/IOM Sezione di Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy.
Andrea BosinDepartment of Physics, University of Cagliari, Cittadella Universitaria di Monserrato, 09042 Monserrato, Italy.ORCID 0000-0001-6300-5712
Silvia Acosta-GutiérrezDepartment of Chemistry, University College, London WC1E 6BT, UK.ORCID 0000-0002-0122-9769
Matteo CeccarelliDepartment of Physics, University of Cagliari, Cittadella Universitaria di Monserrato, 09042 Monserrato, Italy.ORCID 0000-0003-4272-902X
University of Cagliari · ITIstituto Nazionale di Fisica Nucleare, Sezione di Cagliari · ITUniversity College London · GB

Funding

IMI 115525MIUR 2015795S5W
6 · The paper itself

Abstract

Modern medicine relies upon antibiotics, but we have arrived to the point where our inability to come up with new effective molecules against resistant pathogens, together with the declining private investment, is resulting in the number of untreatable infections increasing worldwide at worrying pace. Among other pathogens, widely recognized institutions have indicated Gram-negative bacteria as particularly challenging, due to the presence of the outer membrane. The very first step in the action of every antibiotic or adjuvant is the permeation through this membrane, with small hydrophilic drugs usually crossing through protein channels. Thus, a detailed understanding of their properties at a molecular level is crucial. By making use of Molecular Dynamics simulations, we compared the two main porins of four members of the

Indexed as

Anti-Bacterial Agentsbeta-Lactamase InhibitorsCell Membrane PermeabilityEnterobacteriaceaeGram-Negative BacteriaMolecular Dynamics SimulationPorinsStatic ElectricityAnti-Bacterial Agentsbeta-Lactamase InhibitorsPorinsbacterial porinsbeta-lactamase inhibitorsfree energy surfaceGram-negative bacteriamolecular dynamics simulationspermeation of small molecules

Identifiers

PMID33291474
PMCPMC7730927
OpenAlexW3113287811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.